GGA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.140200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.418200E-01
Normal-vs-Stage2
3.099000E-01
Normal-vs-Stage3
2.649200E-01
Normal-vs-Stage4
2.965600E-01
Stage1-vs-Stage2
5.820400E-01
Stage1-vs-Stage3
2.689200E-01
Stage1-vs-Stage4
5.560000E-01
Stage2-vs-Stage3
3.527000E-01
Stage2-vs-Stage4
7.749800E-01
Stage3-vs-Stage4
3.113600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.162200E-01
Normal-vs-AfricanAmerican
3.191600E-01
Normal-vs-Asian
2.779000E-01
Caucasian-vs-AfricanAmerican
9.790800E-01
Caucasian-vs-Asian
4.185800E-02
AfricanAmerican-vs-Asian
1.734020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.064400E-01
Normal-vs-Female
3.250400E-01
Male-vs-Female
2.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.646600E-01
Normal-vs-Age(41-60Yrs)
3.307600E-01
Normal-vs-Age(61-80Yrs)
3.070800E-01
Normal-vs-Age(81-100Yrs)
2.937600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.873000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.924800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.337790E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.672560E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.552820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.916600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.025800E-01
Normal-vs-Daily Drinker
2.954200E-01
Normal-vs-Weekly Drinker
2.897600E-01
Normal-vs-Occasional Drinker
3.340200E-01
Normal-vs-Social Drinker
3.207200E-01
Non Drinker-vs-Daily Drinker
8.166600E-01
Non Drinker-vs-Weekly Drinker
6.507800E-01
Non Drinker-vs-Occasional Drinker
4.398400E-01
Non Drinker-vs-Social Drinker
6.513800E-01
Daily Drinker-vs-Weekly Drinker
8.141000E-01
Daily Drinker-vs-Occasional Drinker
2.777800E-01
Daily Drinker-vs-Social Drinker
4.397000E-01
Weekly Drinker-vs-Occasional Drinker
2.170600E-01
Weekly Drinker-vs-Social Drinker
3.501800E-01
Occasional Drinker-vs-Social Drinker
7.713600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.854600E-01
Normal-vs-Grade 2
2.103400E-01
Normal-vs-Grade 3
1.967430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.349400E-01
Grade 1-vs-Grade 3
1.482000E-01
Grade 1-vs-Grade 4
3.854600E-01
Grade 2-vs-Grade 3
4.884800E-01
Grade 2-vs-Grade 4
2.103400E-01
Grade 3-vs-Grade 4
1.967430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.226800E-01
Normal-vs-NonDiabetic
3.036800E-01
Diabetic-vs-NonDiabetic
3.475000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.031600E-01
Normal-vs-NoPancreatitis
3.108200E-01
Pancreatitis-vs-NoPancreatitis
7.741400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.262800E-01
Normal-vs-N1
3.068000E-01
N0-vs-N1
4.298400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.250400E-01
Normal-vs-TP53-NonMutant
2.898200E-01
TP53-Mutant-vs-TP53-NonMutant
2.602200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
